格隆汇3月18日|丹麦减肥药物制造商诺和诺德因违反英国制药商行为准则而遭暂停会员资格两年后,再次成为英国制药业协会成员。英国制药工业协会周一在一份声明中表示,在对诺和诺德合规程序和治理进行广泛的审计之后,恢复其会员资格。审计由英国处方药产业行为准则管理局执行,该管理局负责管理英国处方药产业协会(ABPI)的行为准则。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.